Apiary Labs launches SurveillanceIQ to connect disease signals
Apiary Labs has released SurveillanceIQ, a population-level disease surveillance platform for public health agencies in the U.S. The system is designed to combine fragmented data sources, verify emerging threats and help teams coordinate faster responses across jurisdictions.
Why it matters: - Public health agencies have more disease data than ever, but the challenge is turning scattered signals into decisions fast enough to matter. - SurveillanceIQ is built to help epidemiologists detect emerging threats earlier, weigh evidence across sources and coordinate responses before cases rise. - The platform is available to agencies in all 50 states, the District of Columbia and U.S. territories.
What happened: - Apiary Labs announced SurveillanceIQ, a population-level disease surveillance and early-warning platform. - The company said the platform is available today to public health agencies. - SurveillanceIQ is aimed at state, territorial, county and city health departments, preparedness organizations and cross-jurisdictional response teams. - The company is based in Austin, Texas.
The details: - SurveillanceIQ currently tracks 218 syndromes, including tick-borne conditions such as alpha-gal syndrome. - The platform can add new syndromes as they are identified. - Epidemiologists can investigate unusual patterns, weigh supporting evidence and evaluate response options in one place. - Core capabilities include multi-source disease intelligence across indicator-based, syndromic, wastewater, genomic, event-based, environmental and animal-health surveillance. - Teams can upload their own data and analyze it alongside CDC and other public data sources. - SIGHTLINE Ask lets users explore public health data in plain language, with traceable calculations, confidence indicators and safeguards against unsupported conclusions. - The system flags unusual or unclassified genomic signals that warrant further scientific study. - It projects where disease threats may emerge or spread next to support preparedness planning. - It models scenario planning such as travel restrictions or medical countermeasure deployment across jurisdictions, while keeping modeled outcomes separate from observed evidence. - SurveillanceIQ records investigation histories and maintains a 7-1-7 ledger to measure performance against the global outbreak target for detection, notification and response. - The platform spans national, state, territorial and local jurisdictions with jurisdiction-specific environments for local investigations. - SurveillanceIQ works alongside existing public health infrastructure and does not replace established reporting systems. - Its core surveillance workflows do not require patient-level clinical records.
Between the lines: - The product reflects a shift from collecting more data to connecting and validating that data across systems. - Apiary Labs is positioning SurveillanceIQ as decision support, not just another dashboard. - That distinction matters for agencies that need defensible actions across multiple jurisdictions. - Public health teams in three U.S. cities used SurveillanceIQ during the 2026 FIFA World Cup to consolidate surveillance information and support situational awareness. - The company’s pitch suggests growing demand for tools that can help agencies balance speed, evidence and coordination during fast-moving outbreaks.
What's next: - Eligible health departments may be able to fund adoption through existing federal sources, including CDC’s Public Health Infrastructure Grant, subject to grant terms. - Apiary Labs says teams can typically be onboarded in as little as two weeks. - Agencies interested in the platform can contact press@apiary-labs.com for more information. - The company says SurveillanceIQ is built to support the next generation of public health intelligence as forecasting and surveillance capabilities advance.
The bottom line: - Apiary Labs is betting that public health agencies need a single system to verify disease signals, forecast risk and coordinate action before outbreaks escalate.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Today in Healthcare
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.